Intertek to Exhibit and Present at SOT 2018

December 20, 2017

Intertek, a leading Total Quality Assurance provider to industries worldwide, is pleased to announce that they will be attending and exhibiting at the Society of Toxicology (SOT) annual meeting taking place in San Antonio from March 11-15, 2018.

The SOT annual meeting and ToxExpo will bring together more than 335 exhibitors, including laboratories, manufacturers, suppliers, researchers, and more. Exhibitors will be able to showcase the latest products and services related to toxicology and biomedical research to stakeholders such as scientists, executives, and industry leaders. Attendees will benefit from more than 160 scientific sessions, including education-career development sessions, historical highlights, Informational sessions, platform/poster sessions, regional interest sessions, roundtables, symposia, workshops, and SOT awards lectures.

During the event, Intertek Pharmaceutical Services, San Diego and Health, Environmental & Regulatory Services (HERS) will be co-hosting an exhibitor educational session titled "Bioanalysis and Toxicology Challenges with Antibody Drug Conjugates (ADC)" on March 13 from 1:30 - 2:30 PM in room 217C. ADCs are complex molecules that require a science and data-driven approach unique to each ADC. They present unique bioanalytical challenges as they tend to be complex heterogeneous mixtures of multiple species with a range of drug-to-antibody ratios. Andrew Macintyre, Director, Chemicals & Pharmaceuticals, San Diego, and Lindsay Donald, VP, Pharmaceuticals, HERS, will present during this session. ADCs are a relatively new class of compounds and there are no regulatory guidelines which specifically address their development. There are several quite unique challenges which must be considered in their safety assessment including immunogenicity assay requirements and bioanalysis assay complexity. Mr. Donald states, “this class of compounds has challenges in toxicology preclinical testing that need to be fully addressed to avoid drug development delays in the clinic”. This presentation will discuss ADC preclinical study design, anti-drug antibody assay development and validation, and other challenges to avoid failure due to safety issues and ensure a safe and effective drug product.

In addition, attendees are invited to attend posters sessions in the CC Exhibit Hall which will provide first-hand knowledge of Intertek's latest scientific research projects. HERS will present 5 research posters titled:

  • Developing an Intake Approach to Assess Expected Intake of Nutrients from GM Plants
    Monday, March 12, 10:45 AM - 12:15 PM | Poster No. P871
    Authors: Kerry Finch, Annette Lau, Danika Martyn
  • Development of a No Significant Risk Level for Furfuryl Alcohol and Assessment of Exposures from Coffee Consumption for Compliance with California Proposition 65
    Monday, March 12, 10:45 AM - 12:15 PM | Poster No. P858
    Authors: Tom Jonaitis, Danika Martyn, Annette Lau, Barry Lynch, Lois Haighton
  • Low/No-Calorie Sweeteners and Effects on the Gut-Microbiota: Assessing the Nonclinical and Clinical Data and Implications for Food Safety
    Monday March 12, 10:45 AM - 12:15PM | Poster No. P847
    Authors: Alexandra Lobach, Ashley Roberts
  • The Use of Standard Toxicology Data to Substantiate the Safety of Feed Additives
    Wednesday, March 14, 3:00 PM- 4:30 PM | Poster No. P426
    Authors: Winnie Ng, Brandon Walters
  • Derivation of a Parenteral PDE Value for Zirconium Pursuant to the ICH Q3D Elemental Impurities Guideline
    Wednesday, March 14, 3:00PM - 4:30 PM | Poster No. P346
    Authors: Hana Fikree, Lois Haighton, Jeffrey Card

Attendees are encouraged to meet with our experts at booth #860 on the Tox Expo floor for consultation. Register today and join us in San Antonio!

To learn more about our services for a wide range of pharmaceuticals, biopharmaceuticals, food, and supplement products within the larger Intertek organization, please visit:

 

About Intertek

Total Quality. Assured.

Intertek is a leading Total Quality Assurance provider to industries worldwide. Our network of more than 1,000 laboratories and offices and over 42,000 people in more than 100 countries, delivers innovative and bespoke Assurance, Testing, Inspection and Certification solutions for our customers' operations and supply chains. Intertek Total Quality Assurance expertise, delivered consistently, with precision, pace and passion, enabling our customers to power ahead safely.

intertek.com

 

For Media Information:

Tracy Veale
Global Marketing Manager
T: +1 905 542 2900
E: tracy.veale@intertek.com

For Technical Information:

Lois Haighton
Director, Food & Nutrition
T: +1 905-542-2900
E: lois.haighton@intertek.com

Lori Payne
Director, Business Development
T: +1 858-226-0248
E: lori.payne@intertek.com